reviewNature Reviews CardiologyJul 14, 2020Closed access

SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control

MCMartín CowieMFMiles Fisher

Royal Brompton Hospital · Lung Institute · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

770
total citations
FWCI
54.45
Percentile
100%
References
159
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Medicine
  • Heart failure with preserved ejection fraction
  • Heart failure
  • Albuminuria
  • Empagliflozin
  • Diabetes mellitus
  • Internal medicine
  • Ejection fraction
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.